Award
Delivery Order #SPE2DR26FT7UA
Short-Term Delivery Order for Clot-Dissolving Medication by AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$5,596.80
Ceiling
$5,596.80
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26FT7UA
NAICS
424210
This award is a short-term delivery order contract issued under an existing Indefinite Delivery Vehicle (IDV) for pharmaceutical products. The recipient, AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, is tasked with supplying Cathflo Activase 2 mg vials, a medication used to dissolve blood clots. This delivery order supports the Department of Defense's ongoing need for essential pharmaceutical products. Being a delivery order under a competitively awarded IDV ensures a streamlined procurement process. The performance period is very brief, spanning a single day, reflecting a rapid procurement to meet specific immediate requirements. This award complements AmerisourceBergen's broader pharmaceutical service contract, ensuring timely access to critical medical treatments within military healthcare systems.
Description
4571119574!CATHFLO ACTIVASE 2 MG VIALS